Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants

EPO administration did not significantly increase the risk of ROP of any stage reported or Stage ≥3. Further clinical trials investigating the impact of EPO on ROP in premature infants should include all confounding factors to clarify this important issue.